A open-label, single-sequence, 3-period, crossover study to evaluate the pharmacokinetic drug–drug interactions of drug when LCZ696 was coadministered with hydrochlorothiazide in healthy subjects.

Trial Profile

A open-label, single-sequence, 3-period, crossover study to evaluate the pharmacokinetic drug–drug interactions of drug when LCZ696 was coadministered with hydrochlorothiazide in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Sacubitril/valsartan (Primary) ; Hydrochlorothiazide
  • Indications Heart failure
  • Focus Pharmacokinetics
  • Acronyms LCZ696/HCTZ DDI study
  • Most Recent Events

    • 11 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top